Göran Bergström

Göran Bergström

Auto-generated profile, based on publicly available information

Göran Bergström

University of Gothenburg

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2013 in Nature
Verified
Journal Article
Closed access
PDF file
FKFredrik H. Karlsson
Fredrik H. Karlsson
VTValentina Tremaroli
Valentina Tremaroli
INIntawat Nookaew
Intawat Nookaew
GBGöran Bergström
Göran Bergström
CBCarl Johan Behre
Carl Johan Behre
FBFredrik Bäckhed
Fredrik Bäckhed

1 November 2018 in Cell
Verified
Journal Article
Closed access
AKAra Koh
Ara Koh
Antonio MolinaroAntonio Molinaro
Antonio Molinaro
MSMarcus Ståhlman
Marcus Ståhlman
MKMuhammad Tanweer Khan
Muhammad Tanweer Khan
CSCaroline Schmidt
Caroline Schmidt
FBFredrik Bäckhed
Fredrik Bäckhed

1 August 2003 in Genes & Development
Verified
Journal Article
Open access
PDF file
PLPer Lindblom
Per Lindblom
HGHolger Gerhardt
Holger Gerhardt
SLStefan Liebner
Stefan Liebner
AAAlexandra Abramsson
Alexandra Abramsson
MEMaria Enge
Maria Enge
CBChrister Betsholtz
Christer Betsholtz
Several platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) family members display C-terminal protein motifs that confer retention of the secreted factors within the pericellular space. To address the role of PDGF-B retention in vivo, we deleted the retention motif by gene targeting in mice. This resulted in defective investment of pericytes in the microvessel wall and delayed formation of the renal glomerulus mesangium. Long-term effects of lack of PDGF-B retention included severe retinal deterioration, glomerulosclerosis, and proteinuria. We conclude that retention of PDGF-B in microvessels is essential for proper recruitment and organization of pericytes and for renal and retinal function in adult mice.

26 November 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
MUMathias Uhlen
Mathias Uhlen
MKMax J. Karlsson
Max J. Karlsson
AHAndreas Hober
Andreas Hober
ASAnne-Sophie Svensson
Anne-Sophie Svensson
JSJulia Scheffel
Julia Scheffel
ÅSÅsa Sivertsson
Åsa Sivertsson
A database provides information on the relative abundances and locations of human proteins that are predicted to be secreted.

19 June 2015 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
GBG. Bergström
G. Bergström
GBG. Berglund
G. Berglund
ABAnders Blomberg
Anders Blomberg
JBJ. Brandberg
J. Brandberg
GEG. Engström
G. Engström
ARAnnika Rosengren
Annika Rosengren
Cardiopulmonary diseases are major causes of death worldwide, but currently recommended strategies for diagnosis and prevention may be outdated because of recent changes in risk factor patterns. The Swedish CArdioPulmonarybioImage Study (SCAPIS) combines the use of new imaging technologies, advances in large‐scale ‘omics’ and epidemiological analyses to extensively characterize a Swedish cohort of 30 000 men and women aged between 50 and 64 years. The information obtained will be used to improve risk prediction of cardiopulmonary diseases and optimize the ability to study disease mechanisms. A comprehensive pilot study in 1111 individuals, which was completed in 2012, demonstrated the feasibility and financial and ethical consequences of SCAPIS. Recruitment to the national, multicentre study has recently started.

21 September 2021 in Circulation
Verified
Journal Article
Open access
PDF file
GBGöran Bergström
Göran Bergström
MPMargaretha Persson
Margaretha Persson
MAMartin Adiels
Martin Adiels
EBElias Björnson
Elias Björnson
CBCarl Bonander
Carl Bonander
TJTomas Jernberg
Tomas Jernberg
Background: Early detection of coronary atherosclerosis using coronary computed tomography angiography (CCTA), in addition to coronary artery calcification (CAC) scoring, may help inform prevention strategies. We used CCTA to determine the prevalence, severity, and characteristics of coronary atherosclerosis and its association with CAC scores in a general population. Methods: We recruited 30 154 randomly invited individuals age 50 to 64 years to SCAPIS (the Swedish Cardiopulmonary Bioimage Study). The study includes individuals without known coronary heart disease (ie, no previous myocardial infarctions or cardiac procedures) and with high-quality results from CCTA and CAC imaging performed using dedicated dual-source CT scanners. Noncontrast images were scored for CAC. CCTA images were visually read and scored for coronary atherosclerosis per segment (defined as no atherosclerosis, 1% to 49% stenosis, or ≥50% stenosis). External validity of prevalence estimates was evaluated using inverse probability for participation weighting and Swedish register data. Results: In total, 25 182 individuals without known coronary heart disease were included (50.6% women). Any CCTA-detected atherosclerosis was found in 42.1%; any significant stenosis (≥50%) in 5.2%; left main, proximal left anterior descending artery, or 3-vessel disease in 1.9%; and any noncalcified plaques in 8.3% of this population. Onset of atherosclerosis was delayed on average by 10 years in women. Atherosclerosis was more prevalent in older individuals and predominantly found in the proximal left anterior descending artery. Prevalence of CCTA-detected atherosclerosis increased with increasing CAC scores. Among those with a CAC score >400, all had atherosclerosis and 45.7% had significant stenosis. In those with 0 CAC, 5.5% had atherosclerosis and 0.4% had significant stenosis. In participants with 0 CAC and intermediate 10-year risk of atherosclerotic cardiovascular disease according to the pooled cohort equation, 9.2% had CCTA-verified atherosclerosis. Prevalence estimates had excellent external validity and changed marginally when adjusted to the age-matched Swedish background population. Conclusions: Using CCTA in a large, random sample of the general population without established disease, we showed that silent coronary atherosclerosis is common in this population. High CAC scores convey a significant probability of substantial stenosis, and 0 CAC does not exclude atherosclerosis, particularly in those at higher baseline risk.